Zeocin resistance suppresses mutation in hypermutable Escherichia coli.
Bostock
Julieanne M
JM
Antimicrobial Research Centre and Division of Microbiology, School of Biochemistry and Molecular Biology, University of Leeds, Leeds LS2 9JT, UK.
Miller
Keith
K
Antimicrobial Research Centre and Division of Microbiology, School of Biochemistry and Molecular Biology, University of Leeds, Leeds LS2 9JT, UK.
O'Neill
Alexander J
AJ
Antimicrobial Research Centre and Division of Microbiology, School of Biochemistry and Molecular Biology, University of Leeds, Leeds LS2 9JT, UK.
Chopra
Ian
I
Antimicrobial Research Centre and Division of Microbiology, School of Biochemistry and Molecular Biology, University of Leeds, Leeds LS2 9JT, UK.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001761:Bleomycin / Q000494:pharmacology*; D024881:Drug Resistance, Bacterial / Q000235:genetics*; D004926:Escherichia coli / Q000187:drug effects* / Q000235:genetics; D029968:Escherichia coli Proteins / Q000235:genetics; D008826:Microbial Sensitivity Tests; D009154:Mutation; D012293:Rifampin / Q000494:pharmacology; D013489:Suppression, Genetic
D000900:Anti-Bacterial Agents; D029968:Escherichia coli Proteins; D001761:Bleomycin; C105427:Zeocin; D012293:Rifampin